Project Grant R21AI183025
Award Date 8/12/25
Completion Date 7/31/27
Dollars Obligated $433K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Vermont, USA
Similar Awards
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $438,983 to the University of Vermont & State Agricultural College to study the impact of a novel SARS-CoV-2 nucleocapsid protein dimer on viral and cellular processes. The research aims to characterize the biological effects of this stable dimer, which has arisen in several variants of concern, on viral growth...
- This $146,922 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Emory University to study factors modulating the efficiency of influenza A virus (IAV) infection. The researchers will conduct intranasal and aerosol inoculations in guinea pigs to model direct and airborne transmission of IAV, using barcoded viral libraries to assess the intensity of exposure. They will also test...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $817,730 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Vermont & State Agricultural College. The grant, awarded on July 9, 2025, supports the development of new tools to study how the Toxoplasma gondii parasite delivers its "effector" proteins into host cells during the invasion process. This research aims to understand the mechanisms by which T....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $743,752 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Utah. The grant will support research to define how chronic antigen stimulation contributes to epigenetic programming that drives dysfunction in virus-specific CD4+ T cells during chronic viral infection. The project aims to use highly innovative in vivo models and whole genome DNA methylation sequencing...
- This Project Grant award for $185,866.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) supports research to modulate airway epithelial syndecan-1 in a preclinical model of steroid-resistant asthma. The research aims to examine the role of syndecan-1 and its cleavage by the enzyme heparanase in driving inflammation and glucocorticoid resistance in severe allergic asthma. The study...
- This $453,750 Project Grant was awarded on August 1, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to study how certain bacteriophages (phages) can evade the antiviral defense mechanisms of bacteria, including deadly pathogens like Vibrio cholerae. The research aims to determine the counter-defense mechanisms used by a specific phage protein to antagonize the...
- This $3,078,308 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), supports research to determine the TCR-dependent and epigenetic mechanisms that drive secondary CD4+ T cell responses to influenza infection. The research aims to understand how the nature of initial antigen exposure shapes the formation, persistence, and function of CD4+ T cell responses to...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $204,347 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Vermont & State Agricultural College to study the intracellular colonization strategies of Salmonella enterica serovar Typhimurium within human intestinal epithelial cells and macrophages. The research aims to characterize bacterial and host transcripts during Salmonella infection, distinguish between cytosolic and...
- This federal Project Grant award of $856,791.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the role of the ANKEF1 protein in ciliary function and host defense against influenza virus infection. The research, conducted by the Icahn School of Medicine at Mount Sinai, aims to leverage novel mouse models, human iPSC-derived airway epithelial cultures, and...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Allergy and Infectious Diseases Research grant program (CFDA 93.855), provides $463,676 to the University of Maryland, Baltimore for research to enhance the understanding of Fc-mediated effector functions in the context of infectious diseases. The project aims to dissect the mechanisms underpinning Fc-mediated effector functions, with a focus on antibody interactions with a...